Pfizer Considers Relocating Overseas Manufacturing to US Facilities

Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the US

"I was expecting him probably to win," Pfizer's CEO Albert Bourla said of President Donald Trump's election victory.Leigh Vogel via Getty Images; Carl Court via Getty ImagesPfizer's CEO said he may move manufacturing back to the US in response to Donald Trump's tariffs.Albert Bourla said he was not surprised by Trump's victory in November.Trump has threatened to impose tariffs on Mexico, Canada, and China.Albert Bourla, Pfizer's CEO, said on Mon…

Pfizer could shift overseas production to US if Trump's pharma tariffs take hold, CEO says

Pfizer's CEO said the company could shift some overseas drug production to the U.S. if import tariffs floated by President Donald Trump take effect.

Pfizer says more drugs can be made in its US plants for domestic market, if needed

Pfizer CEO Albert Bourla said on Monday that the drugmaker can shift manufacturing for the US market to its existing plants in the US, as the threat of tariffs puts a question mark over global supply chains.

Pfizer may bring some overseas manufacturing to US if required, says chief exec

'If something happens, we will try to mitigate by transferring from manufacturing sites outside to manufacturing sites here'

Pfizer may move outside manufacturing plants to US: CEO amid tariff threats

The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on most goods from Mexico and Canada

Pfizer considers moving overseas production to U.S. amid tariff threats By Investing.com

Pfizer considers moving overseas production to U.S. amid tariff threats